1Weed DL,Coughlin SS.New ethics guidelines for epidemiology background and rationale[].American Journal of Epidemiology.1999
2Beaty TH.Evolving methods in genetic epidemiology.Ill.geneenvironment interaction in epidemiologic research[].Epidemiologic Reviews.1997
3Sherman SL.Evolving methods in genetic epidemiology.IV.approaches to non - Mendelian inheritance[].Epidemiologicreviews.1997
4Beaty TH.Evolving methods in genetic epidemiology.I.analysis of genetic and environmental factors in family stud-ies[].Epidemiologic Reviews.1997
5Andrieu N,Goldstein AM.Epidemiologic and genetic ap-proaches in the study of gene - enviroment interaction: anoverview of available methods[].Epidemiologic Reviews.1998
6Khoury MJ,Yang QH.The future of genetic studies of complexhuman diseases: an epidemilologic perspective[].Epidemiology.1998
7Ellsworth DL,Manolio TA.The emerging importance of geneticsin epidemiologic research.Ill. Bioinformatics and statisticalgenetic methods[].American Journal of Epidemiology.1999
8Ellsworth DL,Manolio TA.The emerging importance of geneticsin epidemiologic research.I. basic concepts in human geneticand laboratory technology[].American Journal of Epidemiology.1999
9Liu BH.Statistical genomics linkage, mapping and QTL analy- sis[]..1998
10Ellsworth DL,Manolio TA.The emerging importance of geneticsin epidemiologic research.ll.Issues in study esign and genemapping[].American Journal of Epidemiology.1999
3[1]Muir CS. Waterhouse J, Mack T, et al. Cancer Incidence in Five Continents: Vol VI [M]. LARC Scientific Publication, 1987.88.
4[2]Parkin DM, Muir CS, Whelan SL, et al. Cancer Incidence in Five Continents: Vol Vl[M]. lARC Scientific Publication. 1992.120.
5[4]Brodie A, Lu Q,Liu Y.et al. Aromatase inhibitors and their antitumor effects in model systems [J ]. Endocr Relat cancer, 1996,6 (2): 205 -210.
6[6]Paakkonen K,Sauramo S,Sarantaus L,et al. Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population[J ].Genetic Epidemiology, 2001,20(2) :239 - 246.
7[7]Kreiss Y,Barak F,Baruch RG,et al. The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer[ J ]. Genetic Testing, 2000,4 (4): 403 - 407
8[8]Gaffney DK, Hemmersmeier J, Holden J, et al. Breast cancer after mantle irradiation for Hodgkin' s disease: correlation of clinical,pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2 [J] .Int J Radiat Oncol Biol Phys,2001,49(2):539 - 546.
9[9]Kollias J, Man S, Marafie M, et al. Loss of heterozygosity in bilateral breast cancer [ J ]. Breast Cancer Research &Treatment, 2000,64 (3):241 - 251.
10[10]Geller G, Tambor ES, Bernhardt BA, et al. Mothers and daughters from breast cancer families :a qualitative study of their perceptions of risks and benefits associated with minor's participation in genetic susceptibility research [J ]. J Am Med Womens Assoc, 2000,55 (5):280 - 284.
